Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Clinical Practice Guidelines : Kawasaki disease
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution | PLOS ONE
Primary care approach to Kawasaki disease | SMJ
Kawasaki disease: AHA statement and recommendations
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation
2017 AHA Guidelines On Kawasaki Disease - A Link And Excerpts - Tom Wade MD
Conference Notes 11-15-2017 — ACMC EM
Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial | Trials | Full Text
Refractory Kawasaki disease: modified methylprednisolone regimen decreases coronary artery dilatation | Pediatric Research
Kawasaki Disease Shock Syndrome: A Single Center Cohort - ACR Meeting Abstracts
Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis | Semantic Scholar
Links To And Excerpts From The AHA 2017 Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association - Tom Wade MD
Clinical and Experimental Pediatrics
Kawasaki Disease - The Leading Cause of Acquired Heart Disease In Children In The USA - Tom Wade MD
Incomplete Kawasaki Disease - YouTube
Kawasaki disease: AHA statement and recommendations
Classical diagnostic clinical criteria of Kawasaki disease prepared by... | Download Scientific Diagram
Kawasaki Disease | Clinician Reviews
Frontiers | Kawasaki Disease
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the Ame
